In Vitro Susceptibility of Mycobacterium ulcerans to Clarithromycin

Buruli ulcer (BU), caused by Mycobacterium ulcerans, was recently recognized by the World Health Organization as an important emerging disease. While antimycobacterial therapy is often effective for the earliest nodular or ulcerative lesions, medical management of BU lesions in patients presenting f...

ver descrição completa

Detalhes bibliográficos

Publicado no:	Antimicrob Agents Chemother
Principais autores:	Portaels, F., Traore, H., De Ridder, K., Meyers, W. M.
Formato:	Artigo
Idioma:	Inglês
Publicado em:	American Society for Microbiology (ASM) 1998
Assuntos:	Susceptibility
Acesso em linha:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC105863/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9687409/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.42.8.2070
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!